Synthesis and biological evaluation of 3,4-dihydro-1H-[1,4] oxazepino [6,5,4-hi] indol-1-ones and 4,6-dihydrooxepino [5,4,3-cd] indol-1(3H)-ones as Mycobacterium tuberculosis inhibitors.

Champciaux B, Raynaud C, Viljoen A, Chene L, Thibonnet J, Vincent SP, Kremer L, Thiery E

Open source

DOI
10.1016/j.bmc.2021.116248
Published
2021 Aug 1
Container
Bioorganic & medicinal chemistry
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.bmc.2021.116248,
  title = {Synthesis and biological evaluation of 3,4-dihydro-1H-[1,4] oxazepino [6,5,4-hi] indol-1-ones and 4,6-dihydrooxepino [5,4,3-cd] indol-1(3H)-ones as Mycobacterium tuberculosis inhibitors.},
  author = {Champciaux B and Raynaud C and Viljoen A and Chene L and Thibonnet J and Vincent SP and Kremer L and Thiery E},
  year = {2021},
  journal = {Bioorganic \& medicinal chemistry},
  doi = {10.1016/j.bmc.2021.116248},
  url = {https://doi.org/10.1016/j.bmc.2021.116248}
}

RIS

TY  - JOUR
TI  - Synthesis and biological evaluation of 3,4-dihydro-1H-[1,4] oxazepino [6,5,4-hi] indol-1-ones and 4,6-dihydrooxepino [5,4,3-cd] indol-1(3H)-ones as Mycobacterium tuberculosis inhibitors.
AU  - Champciaux B
AU  - Raynaud C
AU  - Viljoen A
AU  - Chene L
AU  - Thibonnet J
AU  - Vincent SP
AU  - Kremer L
AU  - Thiery E
PY  - 2021
JO  - Bioorganic & medicinal chemistry
DO  - 10.1016/j.bmc.2021.116248
UR  - https://doi.org/10.1016/j.bmc.2021.116248
ER  - 

APA

B, C., C, R., A, V., L, C., J, T., SP, V., L, K., & E, T. (2021). Synthesis and biological evaluation of 3,4-dihydro-1H-[1,4] oxazepino [6,5,4-hi] indol-1-ones and 4,6-dihydrooxepino [5,4,3-cd] indol-1(3H)-ones as Mycobacterium tuberculosis inhibitors.. Bioorganic & medicinal chemistry. https://doi.org/10.1016/j.bmc.2021.116248

Source records